Previous close | 517.02 |
Open | 521.60 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 509.80 - 524.00 |
52-week range | 308.40 - 600.90 |
Volume | |
Avg. volume | 103,234 |
Market cap | 385.827M |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | 0.13 |
EPS (TTM) | 39.52 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.
Lonza Group ( VTX:LONN ) Full Year 2023 Results Key Financial Results Revenue: CHF6.72b (up 7.9% from FY 2022). Net...
Key Insights The considerable ownership by individual investors in Lonza Group indicates that they collectively have a...